BioCorRx, Inc. Announces Availability of its Start Fresh

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BioCorRx, Inc. Announces Availability of its Start Fresh Program for Treating Addiction in Chicago, Illinois and an Update on Atlanta Opening

Los Angeles, Aug. 18, 2014 (GLOBE NEWSWIRE) --  BioCorRx, Inc.  (BICX), developer of the Start Fresh Program, announces expansion into Illinois with the opening of a Start Fresh Recovery clinic in the Chicago area by Dr. George Fallieras.  BioCorRx, Inc. has a distribution agreement with Dr. Fallieras, Medical Director of Start Fresh Recovery, who currently operates clinics in three other locations.  He has appeared on the Emmy Award-winning show The Doctors, and countless other local media outlets to discuss the Start Fresh Program.  "We are pleased that Dr. Fallieras is continuing the expansion of the Start Fresh Program into an area that is in desperate need of resources to combat the wave of addiction that has swept through the city in recent years," stated CEO Kent Emry. The clinic is located at 8707 Skokie Blvd, Suite 308, Skokie, Illinois 60077 and is ready to begin initial patient consultations now.

It was previously announced that a Start Fresh Recovery clinic would be opening in Atlanta in June, but it was delayed due to leasing issues. The location has been moved to 3193 Howell Mill Road, Suite 104, Atlanta, GA 30327 and is now planned to be open around the second week of September. Dr. Fallieras will also be the owner and medical director of the Atlanta center.

Entering into the Chicago market is another sensible move for BioCorRx, Inc., especially considering the program's expansion into treating opiate addiction.  Heroin use is at historic highs in Chicago and surrounding suburbs.  Users come from all age groups as well as all walks of life, with the largest group of new users being teens and young adults.  Due to a dramatic increase in production in Mexico and the prevalence of street gangs selling the drug, Chicago is considered a hub for cheap, pure heroin.  The epidemic of hard drug abuse around Chicago can in part be contributed to the increase in painkiller abuse in recent years.   A federal survey found that four out of five new heroin users (approximately 79.5%) had previously abused painkillers.  Many addicts quickly progress to heroin because they can achieve a more powerful high for much less money.   This type of serious addiction is causing Chicago families to crumble, while overwhelming healthcare and social services.  The Start Fresh Program can offer a powerful new tool to those combatting addiction, and give the parents of this expanding group of addicted young adults new hope.

The state of Illinois has an estimated population of nearly 13 million people, 8-10 million of which reside in the Chicago Metropolitan Area.  "The Start Fresh Program will have significant positive impact around Chicago where many new addicts are young adults.  These individuals and their families will now have access to the tools offered by Start Fresh to get on the road to recovery before heroin use spirals out of control," says Emry.  "Dr. Fallieras has continually upheld the Start Fresh brand while broadening BioCorRx, Inc.'s revenue stream and we are pleased for the opportunity to work with him through yet another clinic".

Visit the company's new investor relations website www.BICXcorp.com to receive the most up to date company information.

Click here to view Recent National Television Media on the BioCorRx YouTube Channel

Click here for company Facebook page for more stories and media coverage

About BioCorRx, Inc.

BioCorRx, Inc. (OTCQB: BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh Program TM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX, visit  www.B ICXcorp.com .

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Investor Relations SmallCapVoice.com, Inc. 512-267-2430

Scroll down for more posts ▼

Top 10 Most Recent News Articles

York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 1

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 2

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 2

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 1

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 4

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 4

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 2

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading

Top 5 Most Recently Viewed Articles

Hoyne Bancorp's Transition to Stock Holding Company Explained

Updated Category News Views 240

Hoyne Bancorp, Inc. Announces Conversion Approval Hoyne Bancorp, Inc., a leading financial institution, has recently completed a significant milestone in its evolution. This marks an important phase as the organization transitions from a mutual holding company to a stock holding company, a move that is poised to enhance its operational framework. By transforming into a...

Continue Reading
Incyte's INCB123667 Demonstrates Promise for Ovarian Cancer

Updated Category News Views 133

Incyte's Advancements with INCB123667 Incyte, a forward-thinking biopharmaceutical company known for its innovative therapies, has revealed promising early-stage clinical results for its CDK2 inhibitor, INCB123667. This potential game-changer is designed to target advanced solid tumors, particularly ovarian cancer, where there are still significant unmet medical needs....

Continue Reading
GCL SI Highlights Innovations and Solutions for Solar Energy

Updated Category News Views 167

GCL SI Showcases Innovations at Intersolar Europe At Intersolar Europe 2025, GCL System Integration (GCL SI) presents groundbreaking technologies and comprehensive solar solutions, demonstrating its significant role in photovoltaic advancement. From cutting-edge granular silicon to high-efficiency perovskite modules, GCL is at the forefront of global decarbonization...

Continue Reading
8x8, Inc. Celebrates Inclusion in Newsweek's Excellence Ranking

Updated Category News Views 177

8x8, Inc. Recognized by Newsweek for Corporate Excellence 8x8, Inc. (NASDAQ: EGHT) has recently been acknowledged in the prestigious Excellence 1000 Index published by Newsweek. This esteemed ranking celebrates companies demonstrating outstanding practices in various crucial areas such as financial responsibility and social accountability. Understanding the Excellence...

Continue Reading
James Hardie Industries Faces Leadership Change Amid Lawsuit

Updated Category News Views 183

James Hardie Industries Faces Leadership Turmoil Recently, James Hardie Industries plc (NYSE: JHX) announced a significant leadership transition with the departure of its Chief Financial Officer, Rachel Wilson. Ryan Lada has been brought in as her replacement. This change comes in the wake of troubling developments concerning the company's financial practices and investor...

Continue Reading